Hormonal alterations on young morbid obese women;Alteraciones hormonales en mujeres jóvenes con obesidad mórbida

Medicina Clinica

Volumn 116, Issue 9, 2001, Pages 321-323

  Vilà, Ruth ^a   Gutiérrez, Rosa ^b   Granada, María Luisa ^b   Masanés, Rosa María ^c   Grasa, María Del Mar ^a   López, José Antonio Fernández ^a   Remesar, Xavier ^a   Formiguera, Xavier ^b   Foz, Màrius ^b   Alemany, Marià ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c NONE

Author keywords

Acylestrone; Insulin; Leptin; Young obese women

Indexed keywords

HORMONE;

ADULT; AGE; ARTICLE; BLOOD; FEMALE; HUMAN; MORBID OBESITY;

ADULT; AGE FACTORS; FEMALE; HORMONES; HUMANS; OBESITY, MORBID;

EID: 0035836163     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71815-5     Document Type: Article

References (26)

1. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-174.
2. Czech MP, Richardson DK, Smith CJ. Biochemical basis of fat cell insulin resistance in obese rodents and man. Metabolism 1977; 26: 1057-1078.
3. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
4. Arch JRS, Stock MJ, Trayhurn P. Leptin resistance in obese humans: does it exist and what does it mean? Int J Obes 1998; 22: 1159-1163.
5. Remesar X, Tang V, Ferrer E, Torregrosa C, Virgili J, Masanés RM et al. Estrore in food: a factor influencing the development of obesity? Eur J Nutr 1999; 38: 247-253.
6. Fernández-Real JM, Sanchis D, Ricart W, Casamitjana R, Balada F, Remesar X et al. Plasma oestrone fatty acid ester levels are correlated with body fat mass in humans. Clin Endocrinol 1999; 50: 253-260.
7. Sanchis D, Balada F, Grasa MM, Virgili J, Peinado J, Monserrat C et al. Oleoyl estrone induces the loss of body fat in rats. Int J Obes 1996; 20: 588-594.
8. Kaibara A, Moshyedi A, Auffenberg T, Abouhamze A, Copeland EM III, Kalra S et al. Leptin produces anorexia and weight loss without inducing an acute phase response or protein wasting. Am J Physiol 1998; 274: R1518-R1525.
9. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin - toward an understanding of leptin resistance. Diabetes 1997; 46: 717-719.
10. Sanchis D, Adán C, Ardévol A, Grasa MM, Cabot C, Balada F et al. Short-term treatment with oleoyl-oestrone in liposomes (Merlin-2) strongly reduces the expression of the ob gene in young rats. Biochem J 1997; 326: 357-360.
11. Hammond GL. Molecular-properties of corticosteroid binding globulin and the sex-steroid binding-proteins. Endocr Rev 1990; 11: 65-79
12. Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity implications for the insulin-resistance syndrome. J Intern Med 1993; 234: 461-469.
13. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998; 83: 1806-1809.
14. Deurenberg P, Yap M, Van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes 1998; 22: 1164-1171.
15. Ardévol A, Virgili J, Sanchis D, Adán C, Fernández-Real JM, Fernández-López JA et al. A method for the measurement of plasma estrone fatty ester levels. Anal Biochem 1997; 249: 247-250.
16. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4h in normal subjects. Diabetes 1995; 45: 1364-1366.
17. Pijl H, Toornvliet AC, Meinders AE. Serum leptin in normal-weigh: and obese humans. N Engl J Med 1996; 334: 1544-1544.
18. Cabot C, Masanés R, Bulló M, García-Lorda P. Fernández-López JA, Salas-Salvadó J et al. Plasma acyl-estrone levels are altered in obese women. Endocrine Res 2000; 26: 465-476.
19. Adán C, Cabot C, Vilà R, Grasa MM, Masanés RM, Esteve M et al. Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats. Int J Obes 1999; 23: 366-373.
20. Sulcová J, Hill M, Hampl R, Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997; 154: 57-62.
21. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 291-302.
22. Brindley DN. Role of glucocorticcids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes 1995; 19 (Supl 1): 569-575.
23. Kirschbaum C, Prüssner JC, Stone AA, Federenko I, Gaab J Lintz D et al. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 1995; 57: 468-474.
24. Fleshner M, Deak T, Spencer RL, Laudenslager ML, Watkins LR, Maier SF. A long term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure. Endocrinology 1995; 136: 5336-5342.
25. Haourigui C, Salar S, Martin ME, Thobie N, Girard-Globa A, Benarrayag C et al. Postprandrial free fatty acids stimulate activity of human corticosteroid binding globulin. Am J Physiol 1995; 269: E1067-E1075.
26. Fernández-Real JM, Ricart W, Casamitjana R Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity. Clin Endocrinol 1997; 47: 583-588.